BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31898648)

  • 1. Implications of bladder volume on target coverage and dose to critical structures during high dose rate intracavitary brachytherapy for cervical cancer: A dosimetric study.
    Patel RB; Gururajachar JM; Revathy T
    J Cancer Res Ther; 2019; 15(6):1207-1211. PubMed ID: 31898648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
    Wali L; Helal A; Darwesh R; Attar M
    J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
    Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
    Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
    Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
    Teo BK; Bonner Millar LP; Ding X; Lin LL
    Radiother Oncol; 2015 May; 115(2):195-202. PubMed ID: 26002306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.